Kurs
0,00%
Likviditet
0,02 MNOK
Kalender
Tid* | ||
2024-11-06 | - | X-dag bonusutdelning VISTN 0.5 |
2024-11-06 | - | X-dag halvårsutdelning VISTN 0.5 |
2024-10-31 | - | Kvartalsrapport 2024-Q3 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-06-05 | - | X-dag bonusutdelning VISTN 0.5 |
2024-06-05 | - | X-dag halvårsutdelning VISTN 0.5 |
2024-05-23 | - | Årsstämma |
2024-04-24 | - | Kvartalsrapport 2024-Q1 |
2024-02-16 | - | Bokslutskommuniké 2023 |
2024-01-23 | - | X-dag ordinarie utdelning VISTN 0.75 NOK |
2024-01-23 | - | X-dag bonusutdelning VISTN 0.75 |
2023-10-25 | - | Kvartalsrapport 2023-Q3 |
2023-08-23 | - | Kvartalsrapport 2023-Q2 |
2023-05-23 | - | X-dag ordinarie utdelning VISTN 0.00 NOK |
2023-05-22 | - | Årsstämma |
2023-04-27 | - | Kvartalsrapport 2023-Q1 |
2023-02-17 | - | Bokslutskommuniké 2022 |
2022-10-26 | - | Kvartalsrapport 2022-Q3 |
2022-08-19 | - | Kvartalsrapport 2022-Q2 |
2022-05-24 | - | X-dag ordinarie utdelning VISTN 0.00 NOK |
2022-05-19 | - | Årsstämma |
2022-04-27 | - | Kvartalsrapport 2022-Q1 |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-10-28 | - | Kvartalsrapport 2021-Q3 |
2021-08-19 | - | Kvartalsrapport 2021-Q2 |
2021-05-21 | - | X-dag ordinarie utdelning VISTN 0.50 NOK |
2021-05-21 | - | X-dag bonusutdelning VISTN 0.5 |
2021-05-20 | - | Årsstämma |
2021-04-23 | - | Kvartalsrapport 2021-Q1 |
2021-02-19 | - | Bokslutskommuniké 2020 |
2020-10-30 | - | Kvartalsrapport 2020-Q3 |
2020-08-28 | - | Kvartalsrapport 2020-Q2 |
2020-06-24 | - | Extra Bolagsstämma 2020 |
2020-05-20 | - | X-dag ordinarie utdelning VISTN 1.00 NOK |
2020-05-19 | - | Årsstämma |
2020-04-23 | - | Kvartalsrapport 2020-Q1 |
2020-02-28 | - | Bokslutskommuniké 2019 |
2019-10-25 | - | Kvartalsrapport 2019-Q3 |
2019-08-29 | - | Kvartalsrapport 2019-Q2 |
2019-05-23 | - | X-dag ordinarie utdelning VISTN 0.00 NOK |
2019-05-22 | - | Årsstämma |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-02-19 | - | Bokslutskommuniké 2018 |
2018-10-25 | - | Kvartalsrapport 2018-Q3 |
2018-08-30 | - | Kvartalsrapport 2018-Q2 |
2018-05-25 | - | X-dag ordinarie utdelning VISTN 1.00 NOK |
2018-05-08 | - | Årsstämma |
2018-04-26 | - | Kvartalsrapport 2018-Q1 |
2018-02-27 | - | Bokslutskommuniké 2017 |
2017-11-03 | - | X-dag bonusutdelning VISTN 7 |
2017-11-02 | - | Extra Bolagsstämma 2017 |
2017-10-27 | - | Kvartalsrapport 2017-Q3 |
2017-08-31 | - | Kvartalsrapport 2017-Q2 |
2017-05-26 | - | X-dag ordinarie utdelning VISTN 1.00 NOK |
2017-05-24 | - | Årsstämma |
2017-04-26 | - | Kvartalsrapport 2017-Q1 |
2017-02-28 | - | Bokslutskommuniké 2016 |
2016-10-31 | - | Kvartalsrapport 2016-Q3 |
2016-08-30 | - | Kvartalsrapport 2016-Q2 |
2016-05-25 | - | X-dag ordinarie utdelning VISTN 0.60 NOK |
2016-05-24 | - | Årsstämma |
2016-04-28 | - | Kvartalsrapport 2016-Q1 |
2016-02-23 | - | Bokslutskommuniké 2015 |
2015-10-29 | - | Kvartalsrapport 2015-Q3 |
2015-08-26 | - | Kvartalsrapport 2015-Q2 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Oslo, Norway, 21 October 2021
Vistin Pharma ASA will release its third quarter 2021 results on Thursday 28th of October 2021. Vistin Pharma will host a conference call for all shareholders and interested parties on Thursday 28th of October at 08:30 CET. There will be a Q&A session following the management discussion.
The conference call will be held in English.
The third quarter conference call will be available via web and audio through the following access points:
Telephone conference:
Confirmation Code: 1860729
International dial-In: +44 (0) 2071 928338
Norway, Oslo: +47 21563015
United States, New York: +1 6467413167
Webcast:
https://edge.media-server.com/mmc/p/u59e5tiq
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.